Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

319
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
319
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

113
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
113
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

81
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
81
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

150
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
150
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

74
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
74
Censoring Survival Data01:09

Censoring Survival Data

55
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
55

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond Bonferroni: new multiple contrast tests for time-to-event data under non-proportional hazards.

Lifetime data analysis·2026
Same author

Additional Value of Pertechnetate Scintigraphy to American College of Radiology Thyroid Imaging Reporting and Data Systems and European Thyroid Imaging Reporting and Data Systems for Thyroid Nodule Classification in Euthyroid Patients.

Cancers·2025
Same author

Confirmatory Adaptive Designs for Clinical Trials With Multiple Time-to-Event Outcomes in Multi-state Markov Models.

Biometrical journal. Biometrische Zeitschrift·2024
Same author

Preserflo MicroShunt versus Trabeculectomy: Efficacy and Surgical Success within a Heterogenous Patient Cohort.

Life (Basel, Switzerland)·2024
Same author

Sample Size Calculation Under Nonproportional Hazards Using Average Hazard Ratios.

Biometrical journal. Biometrische Zeitschrift·2024
Same author

Two-sample survival tests based on control arm summary statistics.

PloS one·2024

Related Experiment Video

Updated: May 22, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

Adaptive Weight Selection for Time-To-Event Data Under Non-Proportional Hazards.

Moritz Fabian Danzer1, Ina Dormuth2

  • 1Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.

Statistics in Medicine
|March 17, 2025
PubMed
Summary

This study introduces a flexible clinical trial design for time-to-event endpoints, improving robustness when proportional hazards assumptions are uncertain. The adaptive multi-stage approach enhances power and flexibility, saving trials that might otherwise be inconclusive.

Keywords:
adaptive designscombination‐type testsconditional powerinterim analysissurvival dataweighted log‐rank tests

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Related Experiment Videos

Last Updated: May 22, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Survival Analysis

Background:

  • Standard clinical trials for time-to-event endpoints often assume proportional hazards, using a single-stage log-rank test.
  • This rigid approach is problematic when the proportional hazards assumption is violated or effect sizes are unknown.
  • Existing methods lack flexibility, potentially leading to inconclusive trial results.

Purpose of the Study:

  • To introduce a more flexible and robust procedure for clinical trial planning with time-to-event endpoints.
  • To address the limitations of assuming proportional hazards and the lack of prior knowledge on effect sizes.
  • To improve the success rate of clinical trials by offering a more adaptable design.

Main Methods:

  • Employs an adaptive multi-stage design instead of a traditional single-stage approach.
  • Utilizes combination-type tests in the initial stage for robustness under uncertain deviation patterns.
  • Incorporates Royston-Parmar spline models for survival curve extrapolation to inform subsequent stages.

Main Results:

  • Demonstrates through a real-world example that the proposed approach can salvage trials that would otherwise be inconclusive.
  • Simulation studies confirm sufficient statistical power performance.
  • The method maintains greater flexibility compared to standard procedures.

Conclusions:

  • The proposed adaptive multi-stage procedure offers a more flexible and robust alternative for clinical trials with time-to-event endpoints.
  • This approach is particularly beneficial when prior knowledge is limited or the proportional hazards assumption is questionable.
  • The methodology enhances trial success probability and statistical power.